Search for Clinical Trial Results

Sponsored By

Dense Deposit Disease - 6 Studies Found

Status Study
Withdrawn Study Name: Sulodexide Treatment in Patients With Dense Deposit Disease
Condition: Dense Deposit Disease
Date: 2007-12-20
Interventions: Drug: Sulodexide 200 mg per day in an oral gelcap form
Withdrawn Study Name: Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
Condition:
  • Dense Deposit Disease
  • Membranoproliferative Glomerulonephritis<
    Date: 2010-10-13
    Interventions: Drug: Eculizumab 900 mg IV once a week x 4 weeks, 1200 mg
Terminated Study Name: Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease
Condition:
  • Dense Deposit Disease
  • Membranoproliferati
    Date: 2013-01-29
    Interventions: Drug: CDX-1135 Other Names:
    • TP10
    • sCR1
Withdrawn Study Name: TP10 Use in Patients With C3 Glomerulopathy (C3G)
Condition: Dense Deposit Disease
Date: 2014-11-05
Interventions: Drug: TP10 All patients will be enrolled through the University of Iowa. This study will follow a patien
Recruiting Study Name: Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721
Condition:
  • IgAN
  • Lupus Nephritis
  • MN

  • Date: 2016-02-10
    Interventions:
    • Biological: OMS721 Biological:
Not yet recruiting Study Name: A Proof-of-Mechanism Study to Determine the Effect of ACH-0144471 on C3 Levels in Patients With C3G or IC-MPGN
Condition:
  • C3 Glomerulonephritis
  • Dense Deposit Disease